Xiao Huang:DOORM, despite a decline in pharmaceutical investment, why is AI still a hot topic in this field?
DOORM:Despite the overall decline in pharmaceutical investment, AI remains a hot topic because of its enormous potential and tangible results. AI technology can significantly improve the efficiency and success rate of drug development, attracting substantial venture capital. For instance, startups in the AI drug development field can still secure significant funding. Additionally, tech giants like NVIDIA consider AI to be the next frontier in biopharmaceuticals, further boosting investor confidence.
发表回复
要发表评论，您必须先登录。